Literature DB >> 16956873

Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.

Sarz Maxwell1, Dan Bigg, Karen Stanczykiewicz, Suzanne Carlberg-Racich.   

Abstract

Heroin overdose deaths have increased alarmingly in Chicago over the past decade. Naloxone, an opioid antagonist with no abuse potential, has been used to reverse opiate overdose in emergency medical settings for decades. We describe here a program to educate opiate users in the prevention of opiate overdose and its reversal with intramuscular naloxone. Participant education and naloxone prescription are accomplished within a large comprehensive harm reduction program network. Since institution of the program in January 2001, more than 3,500 10 ml (0.4 mg/ml) vials of naloxone have been prescribed and 319 reports of peer reversals received. The Medical Examiner of Cook County reported a steady increase in heroin overdose deaths since 1991, with a four-fold increase between 1996 and 2000. This trend reversed in 2001, with a 20% decrease in 2001 and 10% decreases in 2002 and 2003.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956873     DOI: 10.1300/J069v25n03_11

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  88 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors:  Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal:  J Subst Abuse Treat       Date:  2019-05-09

3.  Preventing opiate overdose deaths: examining objections to take-home naloxone.

Authors:  Alexander R Bazazi; Nickolas D Zaller; Jeannia J Fu; Josiah D Rich
Journal:  J Health Care Poor Underserved       Date:  2010-11

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

5.  A response to the opioid overdose epidemic: naloxone nasal spray.

Authors:  Daniel P Wermeling
Journal:  Drug Deliv Transl Res       Date:  2013-02-01       Impact factor: 4.617

6.  How States Are Tackling the Opioid Crisis.

Authors:  Shalini Wickramatilake; Julia Zur; Norah Mulvaney-Day; Melinda Campopiano von Klimo; Elizabeth Selmi; Henrick Harwood
Journal:  Public Health Rep       Date:  2017-02-02       Impact factor: 2.792

7.  Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment.

Authors:  Morgan Philbin; Robin A Pollini; Rebecca Ramos; Remedios Lozada; Kimberly C Brouwer; Maria Elena Ramos; Michelle Firestone-Cruz; Patricia Case; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2008-03-28

8.  Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.

Authors:  Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin
Journal:  Addiction       Date:  2015-08       Impact factor: 6.526

9.  Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review.

Authors:  Emily Behar; Rita Bagnulo; Phillip O Coffin
Journal:  Prev Med       Date:  2018-06-15       Impact factor: 4.018

10.  Injection drug users trained by overdose prevention programs: responses to witnessed overdoses.

Authors:  Stephen E Lankenau; Karla D Wagner; Karol Silva; Aleksandar Kecojevic; Ellen Iverson; Miles McNeely; Alex H Kral
Journal:  J Community Health       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.